TCT 2022

Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial

Yazan Daaboul speaks with Pablo Salanis about the two-year outcomes of the SUGAR trial.

We Recommend